The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
R85ZVx01dXYnF9h6
